Skip to main content
Natco Pharma Ltd. logo

Natco Pharma Ltd. — Investor Relations & Filings

Ticker · NATCOPHARM ISIN · INE987B01026 LEI · 33580086GIBRWXSNGG39 BSE.NS Manufacturing
Open in API
Filings indexed 1,708 across all filing types
Latest filing 2018-11-05 Regulatory Filings
Country IN India
Listing BSE.NS NATCOPHARM

About Natco Pharma Ltd.

https://www.natcopharma.co.in/

Natco Pharma Ltd. is a vertically integrated organization focused on the development, manufacturing, and marketing of complex generics and active pharmaceutical ingredients (APIs). The company specializes in niche therapeutic areas, maintaining a leadership position in oncology and a significant presence in specialty segments such as hepatology, cardiology, and diabetology. Natco is recognized for its expertise in high-barrier-to-entry products, including complex oral solids and injectables. Its business model emphasizes research and development to deliver affordable versions of life-saving medicines globally. With a robust portfolio of finished dosage formulations and a strong supply chain for APIs, the company serves diverse international markets, including North America, Europe, and emerging economies, through strategic partnerships and direct distribution channels.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2018-11-05 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 70% confidence The document is a notification about an upcoming earnings call scheduled for November 6, 2018, to discuss the financial results for the quarter and half year ended September 30, 2018. It includes details about the conference call logistics, participants, and contact information. There are no actual financial results or detailed financial statements included in the text. The document serves as an announcement of the earnings call rather than the transcript or the earnings release itself. Therefore, it fits best under the category of Call Transcript (CT) as it relates to the earnings call event, but since it is only an announcement and not the transcript, the closest appropriate classification is Call Transcript (CT) with moderate confidence due to the nature of the content being about the call itself.
2018-11-05 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice from the company to stock exchanges about an upcoming Board Meeting scheduled for November 5, 2018. The agenda includes approval of unaudited financial results for the quarter and half-year ended September 30, 2018, and consideration of a buy-back of equity shares. The document also mentions the closure of the trading window as per SEBI regulations. The document is short (1405 characters) and serves as an announcement of a Board Meeting rather than containing actual financial results or detailed report data. It is not a full financial report, earnings release, or capital update but rather a formal notification of a board meeting and agenda items. Therefore, the most appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement and does not fit other specific categories.
2018-10-29 English
Board Meeting — Financial Results/Buyback
Capital/Financing Update Classification · 90% confidence The document is a notice informing the stock exchanges about an upcoming Board Meeting scheduled for November 5, 2018. The agenda includes approval of unaudited financial results for the quarter and half-year ended September 30, 2018, and consideration of a buy-back of equity shares. It also mentions the closure of the trading window as per SEBI regulations. The document does not contain actual financial data or results but is an announcement of a future meeting where such results will be approved and other corporate actions considered. The document length is short (1405 characters), and it serves as a notification rather than a report or detailed financial disclosure. Therefore, it fits best under the category of Capital/Financing Update (CAP) because it announces consideration of a buy-back of shares, which is a capital structure change, and the approval of financial results is only an agenda item, not the results themselves.
2018-10-29 English
Press Release
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 138 characters, indicating it is extremely short and contains no report content. There is no indication of any report, announcement, or filing type. Given the lack of content, the document best fits the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2018-10-15 English
Allotment of ESOP/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying the allotment of equity shares under an Employee Stock Option Scheme (NATSOP2015). It details the number of shares allotted, the face value, and the resulting increase in paid-up share capital. There is no financial statement, earnings data, or management discussion. The content is an announcement of a capital change due to share allotment. Therefore, it fits the category of Share Issue/Capital Change (SHA). The document length is short and it is not a report publication announcement or certification. Hence, the classification is SHA with high confidence.
2018-09-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.